US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
358 deals · US$218bndisclosed · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Aug 2026 | Janus Living | – | – | Follow-on offering | Completed | 464.0 | REITs+1 | Latham & Watkins (issuer)Ballard Spahr (issuer)BofA Securities (lead manager)J.P. Morgan (lead manager)Wells Fargo Securities (lead manager)BNP Paribas (lead manager)Crédit Agricole CIB (lead manager)Mizuho Securities (lead manager)Morgan Stanley (lead manager)RBC Capital Markets (lead manager)Scotiabank (lead manager)Truist Securities (lead manager)BTIG (lead manager)Citizens JMP (lead manager)Huntington Securities (lead manager)M&T Securities (lead manager)Samuel A. Ramirez & Company (lead manager)Raymond James (lead manager)Roberts & Ryan (lead manager)SMBC Nikko Securities (lead manager)Sidley Austin (lead manager) |
| Aug 2026 | Skye Bioscience | – | – | Placement | Announced | 68.0 | Biotech+1 | Leerink Partners (lead manager)MTS Health Partners (lead manager)Mintz (lead manager) |
| Aug 2026 | Robinhood Ventures Fund II | – | – | IPO | Listed | 200.0 | Investment Vehicles | Davis Polk (issuer)Richards, Layton & Finger (issuer)Goldman Sachs (lead manager)Citi (lead manager)J.P. Morgan (lead manager)UBS (lead manager)Wells Fargo Securities (lead manager)Sullivan & Cromwell (lead manager) |
| Aug 2026 | Silence Therapeutics | – | – | Placement | Completed | 201.0 | Biotech+1 | Goodwin (lead manager)Jefferies (lead manager)Morgan Stanley (lead manager)Cantor Fitzgerald (lead manager)William Blair (lead manager) |
| Aug 2026 | Slate Medicines | – | – | Placement | Announced | 245.0 | Biotech+1 | Cooley (issuer) |
| Aug 2026 | Lyntris | – | – | IPO | Listed | 297.5 | Defence & Aerospace+1 | William BlairWillkie Farr & Gallagher (issuer)Latham & Watkins (lead manager)Evercore (lead manager)Baird (lead manager) |
| Aug 2026 | Newbury Street II Acquisition Corp | – | – | Placement | Announced | 31.0 | Robotics+3 | BTIG (lead manager)Loeb & Loeb (lead manager) |
| Aug 2026 | NorthStrive Acquisition Corp I. | – | – | IPO | Listed | 100.0 | Investment Vehicles | Sichenzia Ross Ference Carmel (issuer)D. Boral Capital (lead manager)DLA Piper (lead manager) |
| Aug 2026 | First Breach | – | – | Direct listing | Announced | – | Cybersecurity | RBW Capital Partners (issuer)Lucosky Brookman (issuer) |
| Aug 2026 | Ambros Therapeutics | – | – | Placement | Announced | 150.0 | Biotech+1 | Cooley (issuer) |
| Aug 2026 | Werewolf Therapeutics | – | – | Placement | Announced | 150.0 | Biotech+2 | Leerink Partners (lead manager)Piper Sandler (lead manager)Cantor Fitzgerald (lead manager)Wells Fargo Securities (lead manager)LifeSci Capital (lead manager)Latham & Watkins (lead manager) |
| Aug 2026 | AbCellera Biologics | – | – | Follow-on offering | Completed | 200.0 | Biotech+1 | Goodwin (issuer) |
| Aug 2026 | Amylyx Pharmaceuticals | – | – | Follow-on offering | Announced | 575.2 | Biotech+1 | Goodwin (issuer)Leerink Partners (lead manager)Morgan Stanley (lead manager)Guggenheim Securities (lead manager)LifeSci Capital (lead manager) |
| Aug 2026 | Bleichroeder Acquisition Corp. III | – | – | Placement | Announced | 350.0 | Defence & Aerospace+1 | Latham & WatkinsCantor Fitzgerald (lead manager)Moelis & Company (lead manager)DLA Piper (lead manager) |
| Aug 2026 | JATT III Acquisition Corp | – | – | IPO | Listed | 69.0 | Investment Vehicles | Davis Polk (lead manager) |
| Aug 2026 | Southern Cross Acquisition II Corp. | – | – | IPO | Listed | 76.5 | Investment Vehicles | Robinson & Cole (issuer)D. Boral Capital (lead manager)Norton Rose Fulbright (lead manager) |
| Aug 2026 | Three Lions Acquisition Corp. | – | – | IPO | Listed | 100.0 | Investment Vehicles | Greenberg Traurig (issuer)Appleby (issuer)EarlyBirdCapital (lead manager)Graubard Miller (lead manager) |
| Sep 2026 | Circle Internet Group | – | – | Placement | Completed | 100.0 | Fintech+2 | Latham & Watkins (issuer) |
| Sep 2026 | Electra Therapeutics | – | – | IPO | Announced | 350.0 | Biotech+1 | Cooley (issuer)Jefferies (lead manager)TD Securities (lead manager)Evercore (lead manager)Cantor Fitzgerald (lead manager)Latham & Watkins (lead manager) |
| Sep 2026 | Haymaker Acquisition Corp. V | – | – | IPO | Announced | 250.0 | Investment Vehicles | William Blair |
| Sep 2026 | Pyxis Oncology | – | – | Follow-on offering | Announced | 110.0 | Biotech+1 | Latham & Watkins (lead manager) |
| Sep 2026 | Lianhe Sowell International Group | – | – | Follow-on offering | Announced | 11.0 | Technology | Robinson & Cole (issuer)Ogier (issuer)Guangdong Xinchu Law Firm (issuer)R. F. Lafferty & Co. (lead manager)Sichenzia Ross Ference Carmel (lead manager) |
| Sep 2026 | Plus Automation, Inc. (PlusAI) | – | – | Placement | Announced | 60.0 | Autonomous vehicles+2 | Cohen & Company Capital Markets (lead manager)Lowenstein Sandler (lead manager) |
| Sep 2026 | Suniva | – | – | Placement | Completed | 835.0 | Renewables+2 | Rodman & Renshaw (issuer)J.P. Morgan (issuer)Kilpatrick Townsend & Stockton (issuer)Roth Capital Partners (lead manager)Gibson Dunn (lead manager) |
| Sep 2026 | American Savings Bank, N.A. | – | – | IPO | Listed | 129.0 | Banking | Davis Polk (issuer)Piper Sandler (lead manager) |
| Sep 2026 | ACP Holdings Acquisition Corp. | – | – | Placement | Announced | 120.0 | Autonomous vehicles+2 | Cantor Fitzgerald (lead manager) |
| Sep 2026 | Beta Bionics | – | – | Follow-on offering | Announced | 172.5 | Medtech | Piper Sandler (lead manager) |
| Sep 2026 | Tenon Medical | – | – | Registered direct or warrant-inducement placement | Completed | 2.9 | Medtech | WallachBeth Capital (issuer) |
| Sep 2026 | Marea Therapeutics | – | – | Placement | Announced | 225.0 | Biotech | Cooley (lead manager) |
| Sep 2026 | North Immunology | – | – | Placement | Announced | 180.0 | Biotech | Cooley (lead manager)Jefferies (lead manager)Leerink Partners (lead manager)BofA Securities (lead manager)UBS (lead manager) |
| Sep 2026 | BCB Bancorp | – | – | Follow-on offering | Completed | 98.0 | Banking | Piper Sandler (lead manager) |
| Sep 2026 | EigenQ | – | – | Convertible | Announced | 45.0 | Cybersecurity+1 | Cohen & Company Capital Markets (lead manager)Reed Smith (lead manager) |
| Sep 2026 | Generation Income Properties | – | – | Registered direct or warrant-inducement placement | Announced | 4.3 | REITs | Maxim Group (issuer) |
| Sep 2026 | Orion180 Insurance Group | – | – | IPO | Listed | 240.0 | Insurance | Latham & Watkins (issuer)RBC Capital Markets (lead manager)UBS (lead manager)Raymond James (lead manager)Goldman Sachs (lead manager)Deutsche Bank (lead manager)Citizens JMP (lead manager)Texas Capital Bank (lead manager)Skadden, Arps, Slate, Meagher & Flom (lead manager) |
| Sep 2026 | Host Digital | – | – | Follow-on offering | Announced | 17.5 | Data Centers+1 | Sidley Austin (issuer) |
| Sep 2026 | Teamshares | – | – | Placement | Completed | 225.0 | Business Services+1 | Nelson Mullins Riley & ScarboroughGoldman Sachs (issuer)Mayer Brown (issuer) |
| Sep 2026 | ADARx Pharmaceuticals | – | – | IPO | Announced | 446.3 | Biotech+1 | Cooley (issuer)J.P. Morgan (lead manager)Morgan Stanley (lead manager)TD Securities (lead manager)UBS (lead manager)LifeSci Capital (lead manager)Latham & Watkins (lead manager) |
| Sep 2026 | ADARx Pharmaceuticals | – | – | Placement | Announced | 89.0 | Biotech+1 | J.P. Morgan (lead manager)Morgan Stanley (lead manager)TD Securities (lead manager)UBS (lead manager)LifeSci Capital (lead manager) |
| Sep 2026 | Live Oak Acquisition Corp. VI | – | – | IPO | Listed | 230.0 | Investment Vehicles | Davis Polk (lead manager) |
| Sep 2026 | AAR CORP. | – | – | Placement | Announced | 230.0 | Defence & Aerospace+2 | Goldman Sachs (lead manager) |
| Sep 2026 | Bold Eagle Acquisition Corp. | – | – | Placement | Announced | 335.0 | Cybersecurity+1 | Goldman Sachs (lead manager)Jefferies (lead manager)Davis Polk (lead manager) |
| Sep 2026 | Roze AI | – | – | Direct listing | Announced | – | AI | RBW Capital Partners (issuer)Sichenzia Ross Ference Carmel (issuer)Prest Law (issuer) |
| Sep 2026 | Roze AI | – | – | Placement | Completed | 10.0 | AI | RBW Capital Partners (lead manager) |
| Sep 2026 | Accelevation | – | – | IPO | Listed | 540.0 | Industrial Services | William BlairPiper Sandler (lead manager)Baird (lead manager) |
| – | Andersen Group | Selling stockholders | – | Follow-on offering | Announced | 188.5 | Business Services | Gunderson Dettmer (issuer)Whalen LLP (issuer)Baird (lead manager)Truist Securities (lead manager)UBS (lead manager)William Blair (lead manager)Latham & Watkins (lead manager) |
| – | Braiin | – | – | Direct listing | Announced | – | Technology | Maxim Group (issuer)Winston Taylor (issuer)Steinepreis Paganin (issuer) |
| – | Fitness Champs Holdings | – | – | Follow-on offering | Announced | 5.0 | Fitness+1 | Conyers (issuer)JunHe (lead manager) |
| – | Green Circle Decarbonize Technology | – | – | IPO | Announced | 10.0 | Climate+1 | Nauth LPC (issuer)Conyers (issuer)RBW Capital Partners (lead manager)Manatt, Phelps & Phillips (lead manager) |
| – | Jefferson Capital | – | – | Sell-down | Announced | 205.0 | Specialty finance and leasing+1 | Latham & Watkins (issuer)Simpson Thacher & Bartlett (issuer)Jefferies (lead manager)Keefe, Bruyette & Woods (lead manager)Weil, Gotshal & Manges (lead manager)Citizens JMP (lead manager)Raymond James (lead manager)Truist Securities (lead manager) |
| – | Lakewood-Amedex Biotherapeutics | – | – | Direct listing | Announced | – | Biotech+1 | RBW Capital Partners (issuer) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built